Atamestane

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Atamestane
Atamestane.svg
Clinical data
ATC code
  • None
Legal status
Legal status
Identifiers
Synonyms SH-489; Metandroden; 1-Methylandrosta-1,4-diene-3,17-dione
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C20H26O2
Molar mass 298.419 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Atamestane (developmental code name SH-489), also known as metandroden, as well as 1-methylandrosta-1,4-diene-3,17-dione, is a steroidal aromatase inhibitor that was studied in the treatment of cancer.[1] It blocks the production of estrogen in the body. The drug is selective, competitive, and irreversible in its inhibition of aromatase.[2][additional citation needed]

See also[edit]

  • Boldione (androsta-1,4-diene-3,17-dione)

References[edit]

  1. ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 794–. ISBN 978-1-4757-2085-3. 
  2. ^ el Etreby MF (March 1993). "Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review". J. Steroid Biochem. Mol. Biol. 44 (4-6): 565–72. doi:10.1016/0960-0760(93)90260-4. PMID 7682838. 

External links[edit]

  • Atamestane entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".